Mutaflor® Escherichia coli strain Nissle 1917 Buy Now Yomogi® Saccharomyces cerevisiae (boulardii) – HANSEN CBS 5926 / CNCM I-745 Buy Now Infloran® Bifidobacterium bifidum NCDO 2203 & Lactobacillus acidophilus NCDO 1748 Buy Now

Manufactured in Germany by Ardeypharm and in clinical use for 105 years, a human commensal bacterial E.coli with unique properties and characteristics that makes E.coli Nissle one of the best researched bacterial strains.

Mutaflor® Escherichia coli strain Nissle 1917 (EcN) is the only probiotic in Australia to be AUST R registered and clinically examined for quality, safety and efficacy.

Always read the label and follow the directions for use

Manufactured in Italy by Laboratorio Farmaceutico SIT, Infloran is a probiotic that was previously only found in Australian and New Zealand Neonatal Intensive Care Units.

Infloran was carefully chosen to prevent a condition known as Necrotising Enterocolitis (NEC) in preterm births and aligns with the principles of probiotic supplementation.
Both Bifidobacterium and Lactobacillus are the predominant bacterial species of healthy breastfed infants and Infloran has demonstrated its efficacy and safety in this population.

Always read the label and follow the directions for use

Manufactured in Germany by Ardeypharm, Yomogi® is a medicinal yeast with distinct probiotic properties.

Saccharomyces cerevisiae HANSEN CBS 5926 (medical synonym: Saccharomyces boulardii) is also known as Saccharomyces boulardii CNCM I-745 and often abbreviated to SB or SB Probiotic.

Both clinicians and patients seek this particular strain as it used in the majority of clinical and pharmacological studies to support the efficacy of Saccharomyces boulardii.

Always read the label and follow directions for use

Evidence Based Probiotics – Proven clinical efficacy

The role of our gut microbiota, its influence on our health and indeed its role in disease is well established.

Probiotic supplementation from a clinical perspective is based on a number of factors:

  • Do no harm
  • Careful selection of specific strains with evidence demonstrating ability to alter health outcomes

Characteristics required

  • resistance to gastric acidity
  • ability to colonise and support beneficial intestinal bowel flora
  • antimicrobial properties – antagonistic properties toward pathogens
  • mucosal integrity, contributing to luminal metabolism and stability
  • anti-inflammatory and immunomodulatory effects
  • promote and enhance healthy digestive function

Together with our European partners, we are dedicated to bringing and making available evidence-based medications with many potential applications.

Always read the label and use only as directed. If symptoms persist, talk to your doctor or healthcare professional.

Send us a Message

    Suite 4, 74 Prospect Road, Prospect, SA